- Main
Orientation-dependent CD45 inhibition with viral and engineered ligands
- Borowska, Marta T;
- Liu, Liu D;
- Caveney, Nathanael A;
- Jude, Kevin M;
- Kim, Won-Ju;
- Masubuchi, Takeya;
- Hui, Enfu;
- Majzner, Robbie G;
- Garcia, K Christopher
Published Web Location
https://doi.org/10.1126/sciimmunol.adp0707Abstract
CD45 is a cell surface phosphatase that shapes the T cell receptor signaling threshold but does not have a known ligand. A family of adenovirus proteins, including E3/49K, exploits CD45 to evade immunity by binding to the extracellular domain of CD45, resulting in the suppression of T cell signaling. We determined the cryo-EM structure of this complex and found that the E3/49K protein is composed of three immunoglobulin domains assembled as "beads on a string" that compel CD45 into a closely abutted dimer by cross-linking the CD45 D3 domain, leading to steric inhibition of its intracellular phosphatase activity. Inspired by the E3/49K mechanism, we engineered CD45 surrogate ligands that can fine-tune T cell activation by dimerizing CD45 into different orientations and proximities. The adenovirus E3/49K protein has taught us that, despite a lack of a known ligand, CD45 activity can be modulated by extracellular dimerizing ligands that perturb its phosphatase activity and alter T cell responses.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.